215 related articles for article (PubMed ID: 24646311)
1. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.
Dabelea D; Ma Y; Knowler WC; Marcovina S; Saudek CD; Arakaki R; White NH; Kahn SE; Orchard TJ; Goldberg R; Palmer J; Hamman RF;
Diabet Med; 2014 Sep; 31(9):1064-8. PubMed ID: 24646311
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
Buzzetti R; Spoletini M; Zampetti S; Campagna G; Marandola L; Panimolle F; Dotta F; Tiberti C;
Diabetes Care; 2015 Mar; 38(3):513-20. PubMed ID: 25567348
[TBL] [Abstract][Full Text] [Related]
3. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers associated with severe hypoglycaemia and death in ACCORD.
Chow LS; Chen H; Miller ME; Marcovina SM; Seaquist ER
Diabet Med; 2016 Aug; 33(8):1076-83. PubMed ID: 26261902
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
Lundberg TP; Højlund K; Snogdal LS; Jensen DM
Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of glutamic acid decarboxylase antibody positivity and its association with insulin secretion and sensitivity in autoimmune thyroid disease: A pilot study.
Aksoy DY; Yürekli BP; Yildiz BO; Gedik O
Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):412-6. PubMed ID: 17039421
[TBL] [Abstract][Full Text] [Related]
9. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing.
Colman PG; McNair P; Margetts H; Schmidli RS; Werther GA; Alford FP; Ward GM; Tait BD; Honeyman MC; Harrison LC
Med J Aust; 1998 Jul; 169(2):81-4. PubMed ID: 9700342
[TBL] [Abstract][Full Text] [Related]
10. Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Pilla SJ; Balasubramanyam A; Knowler WC; Lazo M; Nathan DM; Pi-Sunyer X; Clark JM; Maruthur NM;
Autoimmunity; 2018 Dec; 51(8):408-416. PubMed ID: 30661481
[TBL] [Abstract][Full Text] [Related]
11. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.
Vehik K; Lynch KF; Schatz DA; Akolkar B; Hagopian W; Rewers M; She JX; Simell O; Toppari J; Ziegler AG; Lernmark Å; Bonifacio E; Krischer JP;
Diabetes Care; 2016 Sep; 39(9):1535-42. PubMed ID: 27311490
[TBL] [Abstract][Full Text] [Related]
12. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
13. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
14. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
15. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Tsirogianni A; Pipi E; Soufleros K
Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
[TBL] [Abstract][Full Text] [Related]
16. Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.
Vigo A; Duncan BB; Schmidt MI; Couper D; Heiss G; Pankow JS; Ballantyne CM
Braz J Med Biol Res; 2007 Jul; 40(7):933-41. PubMed ID: 17653446
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy.
Bosi EP; Garancini MP; Poggiali F; Bonifacio E; Gallus G
Diabetologia; 1999 Jul; 42(7):840-4. PubMed ID: 10440126
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
19. Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes.
Mottl AK; Lauer A; Dabelea D; Maahs DM; D'Agostino RB; Dolan LM; Gilliam LK; Lawrence JM; Rodriguez B; Marcovina SM; Imperatore G; Kanakatti Shankar R; Afkarian M; Reynolds K; Liese AD; Mauer M; Mayer-Davis EJ;
Diabetes Care; 2013 Nov; 36(11):3633-8. PubMed ID: 23846811
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
